Diaz J*, Cagil Y, Kolli S, Frade-Garcia A, Wang W, Taylor T, Felipez LM, and Muñiz Crim A. “Therapeutic Drug Monitoring of Infliximab During Induction: A Single Center Experience” .
Sierra D, Wood M, Iskowitz S*, Taylor T, Felipez L, Muniz Crim A. “Varicella Immunity in Pediatric IBD: A Review of the South Florida Population”.
Cagil Y* and Caicedo Oquendo LF. “Young Adult with a Rare Cause of Progressive Dysphagia”.
Diaz J*, Frade Garcia A, Pelaez L, Hernandez E, Arboleda R. “Wilson disease and GLUT1 deficiency syndrome – a case report”.
Iskowitz S*, Prieto P, Felipez L, Muniz Crim A. “Disseminated Histoplasmosis During Induction of Adalimumab”.
Iskowitz S*, Prieto P, Felipez L, Muniz Crim A. “Atypical HSP Presentation in an Adult Patient”.
Iskowitz S*, Prieto P, Felipez L, Muniz Crim A. “Adalimumab-Induced Peripheral Neuropathy”.
Liberti A*, Denny V, Reeves-Garcia J. “Mycobacterium and Crohn's Disease: Cause or Coincidence?”
Prieto P*, lskowitz S, Huang A, Pelaez L, Sanchez-Vega C, Hernandez E. “A RARE INFECTIOUS COMPLICATION IN A PATIENT WITH CROHN'S DISEASE AFTER THE USE OF INFLIXIMAB”
Prieto P*, lskowitz S, Huang A, Brathwaite C, Cervantes L, Muniz-Crim A, Felipez L. “CHALLENGING DIAGNOSIS OF A PEDIATRIC PATIENT WITH CROHN'S DISEASE WHO PRESENTED WITH RESPIRATORY SYMPTOMS AFTER TREATMENT WITH VEDOLIZUMAB”.
Prieto P*, Lawand S, Caicedo L. “IBD SGI 7 SERO (+) MARKERS PREDICTING FISTULIZING CROHN'S DISEASE ON ANOTHERWISE HEALTHY PATIENT WITH ULCERATIVE COLITIS”.
Alegria A*, Schissler K*, Hay A, Restrepo R, Laufer P. “Recurrent Bone Pain in a 12-year-old Girl with Ulcerative Colitis”.
Cagil Y*, Diaz J*, Gonzalez E*, and Muniz Crim A. “Improving Influenza Vaccination in IBD Patients Being Treated with Anti-TNF Agents”.